Article
Enhancing evidence-based guidelines using trial emulation in electronic health records: Real-world effects of empagliflozin in people with type 2 diabetes
2025-09-18
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> There is growing interest in widening the use of sodium-glucose co-transporter-2 inhibitors (SGLT2i) to all people with type 2 diabetes mellitus (T2DM). However, pivotal randomised controlled trials (RCTs) evaluated these drugs only in highly selected populations, often lacking generalisability to real-world populations. Understanding the effects of SGLT2i in populations, wh...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 27f1eefe-e33d-58f6-ae59-cb8cfa76eef9
- DOI
- 10.1101/2025.09.17.25335885
